From the source
From the source
From the source
From the source
Isomorphic Labs has closed a $5 billion Series C co-led by Greenoaks and Sequoia Capital, giving founder and chief executive Sir Demis Hassabis one of the largest private war chests in drug development before Isomorphic has put a medicine into human trials. Isomorphic Labs on X…
runtimewire.com